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Methods and Approaches
I N T R O D U C T I O N
Membrane transport proteins are crucial for maintain-
ing the homeostasis of amino acids in the different 
organs and tissues as they are responsible for the absorp-
tion and distribution of amino acids across the different 
cellular membranes and intracellular compartments 
(Christensen, 1990). Because of the large variety of bio-
logical functions of amino acids, dysfunctions of these 
transporters are associated with a large number of dis-
orders such as neuronal excitability dysfunctions or 
metabolic diseases (Bröer and Palacín, 2011).
Amino acid transporters are found in 11 out of the 
50 different SLC (solute carrier) families. The l–amino 
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acid transporter (LAT) family of amino acid transport-
ers, included in the SLC7 cluster, contains eight pro-
teins found in humans (Fotiadis et al., 2013). These 
transporters are the catalytic subunit of the heteromeric 
amino acid transporters (HATs; Fotiadis et al., 2013), 
the only family of amino acid transporters composed by 
two subunits linked by a disulfide bridge: the LAT, also 
named light subunit, and an accessory protein from the 
SLC3 cluster, also known as heavy subunit because of 
the large glycosylated extracellular domain. Congenital 
mutations of HATs are responsible for two pathological 
disorders: cystinuria and lysinuric protein intolerance 
(Palacín et al., 2005). Moreover, LAT1 and xCT are 
often overexpressed in tumor cells, and their role on 
tumor growth is being studied (Fuchs and Bode, 2005; 
McCracken and Edinger, 2013). At the moment, there 
is no atomic structure of the HAT complex. The crys-
tal structure of the ectodomain of the heavy subunit 
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The knowledge of three-dimensional structures at atomic resolution of membrane transport proteins has improved 
considerably our understanding of their physiological roles and pathological implications. However, most struc-
tural biology techniques require an optimal candidate within a protein family for structural determination with (a) 
reasonable production in heterologous hosts and (b) good stability in detergent micelles. SteT, the Bacillus subtilis 
l-serine/l-threonine exchanger is the best-known prokaryotic paradigm of the mammalian l–amino acid trans-
porter (LAT) family. Unfortunately, SteT’s lousy stability after extracting from the membrane prevents its struc-
tural characterization. Here, we have used an approach based on random mutagenesis to engineer stability in SteT. 
Using a split GFP complementation assay as reporter of protein expression and membrane insertion, we created a 
library of 70 SteT mutants each containing random replacements of one or two residues situated in the transmem-
brane domains. Analysis of expression and monodispersity in detergent of this library permitted the identification 
of evolved versions of SteT with a significant increase in both expression yield and stability in detergent with re-
spect to wild type. In addition, these experiments revealed a correlation between the yield of expression and the 
stability in detergent micelles. Finally, and based on protein delipidation and relipidation assays together with 
transport experiments, possible mechanisms of SteT stabilization are discussed. Besides optimizing a member of 
the LAT family for structural determination, our work proposes a new approach that can be used to optimize any 
membrane protein of interest.
© 2016 Rodríguez-Banqueri et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the 
publication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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LATs. WT SteT can be heterologously expressed in Esch-
erichia coli in sufficient amount for functional charac-
terization using radiolabeled substrates (Reig et al., 2007; 
Bartoccioni et al., 2010). Unfortunately, SteT is highly 
unstable in detergent micelles, as judged by its low solu-
bility and large tendency to aggregate at concentrations 
>2 mg/ml, impassable obstacles for the majority of 
structural biology techniques and, in particular, for pro-
tein crystallization.
Protein engineering is one of the most common and 
successful strategies for providing the desirable phys-
ical chemistry properties to a membrane protein for 
structural studies (Bill et al., 2011). In particular, point 
mutations within the TMDs are known to drastically 
increase protein stability in detergent (Smirnova and 
Kaback, 2003; Tate and Schertler, 2009). Also, single 
replacements are enough to stabilize a particular struc-
tural conformer of a membrane protein (Abramson 
et al., 2003; Kowalczyk et al., 2011), lowering the con-
formational heterogeneity in detergent micelles and 
increasing the probability of forming ordered crystals 
for x-ray diffraction and structure determination. Un-
fortunately, finding such mutations is often tedious 
and unsuccessful. Because of the still low amount of 
structural information at high resolution of membrane 
proteins, the prediction of stabilizing mutations using 
rational approaches very often fails. In this scenario, 
the screening of large libraries of mutants generated 
either by site-directed mutagenesis (Serrano-Vega et al., 
2008; Penmatsa et al., 2013) or by random mutagenesis 
(Schlinkmann and Plückthun, 2013) has emerged as an 
excellent strategy to find engineered evolved versions 
of a particular membrane protein with optimal prop-
erties to initiate structural studies such as reasonable 
expression yield (typically >1 mg of pure and active pro-
tein per liter of culture) and stability after solubilizing 
in different detergents.
Here, aiming to advance in the structural and func-
tional knowledge of LATs, we have defined a strategy to 
build evolved versions of SteT with improved expres-
sion yield and stability in detergent, as a mandatory step 
human 4f2 (Fort et al., 2007) reveals a bacterial -gly-
cosidase fold, although lacking the catalytic activity. 
Recently, a low-resolution structural model combined 
with functional and biochemical assays have provided 
important insights regarding the structural arrange-
ment of the two heterodimers of HATs (Rosell et al., 
2014). Nevertheless, getting insights into the functional 
mechanism of these transporters requires an atom-
ic-resolution structure of the LAT subunit. LATs exhibit 
a 12–transmembrane domain (TMD) topology, where 
the N- and C-terminal ends reside in the cytoplasm 
(Fotiadis et al., 2013). The closest structural models 
of LATs are represented by the x-ray crystal structures 
of three prokaryotic transporters: AdiC, ApcT, and GadC 
(Fang et al., 2009; Gao et al., 2009, 2010; Shaffer et al., 
2009; Kowalczyk et al., 2011; Ma et al., 2012), all of them 
belonging to the large amino acid, polyamines, and or-
ganocation (APC) superfamily (Jack et al., 2000), where 
the LAT family is included. These structures exhibit 
the 5 + 5 inverted repeat fold shared by different and 
nonrelated families of transporters (Shi, 2013). The 
structural conformations represented by these crystal 
structures have provided an overall view of the struc-
tural rearrangement of LATs during transport. How-
ever, the low amino acid identity (<20%) of LATs with 
AdiC, ApcT, or GadC makes necessary the search for 
better paradigms of LATs with closer amino acid se-
quence identity to identify the molecular determinants 
of substrate recognition and translocation.
SteT, the l-serine/l-threonine antiporter of Bacillus 
subtilis is the first characterized prokaryotic member of 
LATs (Reig et al., 2007; Bartoccioni et al., 2010). Se-
quence alignments of SteT with LATs reveal amino acid 
identities ranging from 26 to 30% (Fig. 1; Reig et al., 
2007). Also, a phylogenetic tree of the APC superfamily 
situates SteT within the LAT family (Reig et al., 2007). 
Most importantly, SteT shares the transport mechanism 
of the majority of LATs, that is, obligatory amino acid 
exchange activity together with a low substrate specificity 
(Reig et al., 2007; Bartoccioni et al., 2010). These char-
acteristics situate SteT as an ideal bacterial paradigm of 
Figure 1. Multiple alignments of SteT and human LATs. The figure only shows the alignment of the regions where SteT and human 
LATs are more conserved (TMDs 1, 2, 6, 7, and 8). The full sequence of these transporters have 30% amino acid identity (Reig 
et al., 2007). Lines above the sequences define the SteT TMDs. Residues totally conserved among these transporters are indicated by 
an asterisk. Residues of LAT-1 predicted to interact with the substrate (Geier et al., 2013) and conserved in SteT are highlighted with a 
gray background.
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was induced overnight with 0.3 µg/ml ANTET at 30°C. Thereaf-
ter, GFP1–10 was induced after adding 0.4 mM IPTG and incubat-
ing for 1 h at 30°C. Cells were collected by centrifugation, washed 
twice with PBS, and resuspended in PBS at a final OD600 of 0.2. 
Finally, 200 µl of each sample was transferred into a 96-well plate 
to measure the GFP fluorescence generated after GFP comple-
mentation. Fluorescence background from noninduced cells was 
subtracted from each measurement. Values of expression were 
annotated as relative values of SteT WT expression.
Analysis of stability of mutants by fluorescence size 
exclusion chromatography (SEC [FSEC]) in n-dodecyl--d-
maltopyranoside (DDM)
200 ml of a bacterial culture harboring a given pTET-SteTmu-
tant-GFP11 and pETGFP1–10 were sequentially induced with ANTET 
and IPTG as described in the previous section, and plasma mem-
branes were isolated as described earlier (Bartoccioni et al., 2010). 
In brief, cells were pelleted after centrifuging at 5,000 g for 15 min 
at 4°C, washed once with ice-cold lysis buffer (20 mM Tris-Base, 
pH 8.0, and 350 mM NaCl), resuspended with the same buffer at 
0.2 g of cells/ml of buffer and disrupted by passage through a cell 
disruptor (UK Constant Systems), three times at 20,000 psi. Cell 
debris and unbroken cells were removed after a first centrifugation 
(1 h, 15,000 g, and 4°C), and the supernatant was then ultracen-
trifuged (2 h, 200,000 g, and 4°C) to isolate the membranes. The 
resulting membrane pellet was resuspended and homogenized in 
resuspension buffer (20 mM Tris-Base, pH 8.0, 150 mM NaCl, and 
10% [wt/vol] glycerol), adjusting the total protein concentration 
at 10 mg/ml. Membranes were flash frozen in liquid nitrogen 
and stored at 80°C until use. Membrane suspensions were sol-
ubilized in 1% (wt/vol) DDM (Affymetrix) for 1 h at 4°C. Insol-
uble material was removed after ultracentrifugation (120,000 g, 
1 h, 4°C), and 500 µl of the DDM-solubilized membranes was 
injected into a Superose 6 10/300 GL column (GE Healthcare) 
equilibrated with 20 mM Tris-Base, pH 7.6, 150 mM NaCl, and 
0.05% (wt/vol) DDM. 200-µl fractions from the column elu-
tion were collected in a 96-well plate, and GFP fluorescence was 
measured in a fluorescent plate reader and plotted versus the 
elution time to construct the FPLC chromatogram. To quantify 
the degree of monodispersity of each SteT mutant with respect 
to WT, a parameter called index of monodispersity (IM) was 
calculated from each FSEC chromatogram according the follow-
ing expression:
 IM
N FSEC
N FSEC
WT
SteT variant
=
−
−
∫
∫
13
17
13
17
ml
ml
ml
ml ,  (1)
where ∫ refers to the area under the curve of the normalized FSEC 
chromatogram (N  FSEC) between the 13 and the 17 ml of elu-
tion. This interval of elution volume includes the main elution 
peak of SteT WT monomer (around 15 ml).
Detergent screening
10 mg/ml of plasma membranes prepared as described in the 
previous section was solubilized in 1% (wt/vol) n-decyl--d-maltopy-
ranoside (DM), n-octyl--d-glucopyranoside (OG), 6-cyclohexyl-1-hexyl- 
-d-maltoside (Cymal-6), or n-dodecyl-N,N-dimethylamine-N-oxide 
(LDAO; Affymetrix) for 1 h at 4°C. After ultracentrifugation 
(120,000 g, 1 h, and 4°C), solubilization efficiency was calcu-
lated from the GFP fluorescence ratio of the solubilized mem-
brane fraction versus the nonsolubilized pellet. FSEC analysis 
was performed as in the experiments with DDM. In all of the 
experiments, the column was equilibrated with 20 mM Tris-Base, 
pH 7.6, 150 mM NaCl, and 0.05% (wt/vol) DDM.
toward tridimensional structure determination of this 
transporter. First, we have generated a library of SteT ran-
dom mutants. Second, optimized versions of SteT were 
identified using a screening method that combined the 
measurement of protein expression yield in E. coli cells 
and the analysis of its aggregation in detergent micelles 
as a measure of stability. Finally, the two best-optimized 
mutants were purified and their stability challenged in 
conditions typically used for membrane protein crystal-
lization: high protein concentration and stability in de-
tergents more suitable for crystallization. The possible 
mechanisms of SteT stabilization caused by these muta-
tions are also discussed.
M AT E R I A L S  A N D  M E T H O D S
Construction of a SteT random library
A codon-optimized cDNA encoding SteT for expressing in E. coli 
(GenScript) was cloned into the pTETGFP11 plasmid (provided by 
G.S. Waldo, Bioscience Division, Los Alamos National Laboratory, 
Los Alamos, NM; Cabantous and Waldo, 2006), generating pTET-
SteT-GFP11, which includes the first 15 residues of the superfolder 
GFP (GFP11 fragment; Pédelacq et al., 2006) at the C-terminal end 
of SteT. The resulting plasmid pTET-SteT-GFP11 was subjected to 
error-prone PCR random mutagenesis using the GeneMorph II EZ-
Clone Domain Mutagenesis kit (Agilent Technologies), focusing 
only on the SteT coding region. We optimized the PCR setting con-
ditions according the manufacturer’s instructions to obtain the de-
sired mutational rate (1–2 amino acid substitution on each clone). 
The PCR product was then used as megaprimers in a second PCR 
reaction using pTET-SteT-GFP11 as a template to obtain pTET-SteT-
mutants-GFP11. This second PCR reaction containing pTET-SteT-
mutants-GFP11 was directly transformed in E. coli BL21(DE3) cells 
harboring the plasmid pETGFP1–10, which encodes residues 16–230 
of the superfolder GFP (also donated by G.S. Waldo; Cabantous 
and Waldo, 2006). Transformed cells were plated overnight at 37°C 
in a nitrocellulose filter paper (Amersham Hybond-N; GE Health-
care) lying on top of a Luria broth (LB) agar plate containing 
the antibiotics spectinomycin and kanamycin. Once E. coli colonies 
appeared, we tested in the same colonies the expression of the cor-
responding SteTmutants-GFP11. Expression was initiated by transfer-
ring the filter paper into a new LB-agar plate containing 0.3 µg/ml 
anhydrotetracycline (ANTET) and incubating for 3 h at 30°C. After 
the incubation, the filter paper was moved to a new LB agar plate 
containing no inducing agent to remove the inducing agent and 
therefore to stop SteTmutants-GFP11 expression. Next, GFP1–10 
was induced by transferring the filter paper into a new LB agar 
plate containing 0.4 mM isopropyl -d-thiogalactoside (IPTG) fol-
lowed by 3-h incubation at 30°C. Green E. coli colonies indicating 
the expression of a given SteTmutant-GFP11 after complementation 
with GFP1–10 were observed under UV or blue light using a stereo 
fluorescence microscope (Leica Biosystems). These green colonies 
were cultured and plasmids were isolated for DNA sequencing to 
identify and localize the position of each point mutation. Only sin-
gle or double mutants with amino acid substitutions in TMDs were 
included in the SteT random library. SteT TMDs were defined 
using a previous 3-D model that used the APC bacterial amino acid 
transporter AdiC as template (Bartoccioni et al., 2010).
Expression screening of SteT mutants using  
the GFP split system
20 ml E. coli BL21(DE3) harboring each pTET-SteTmutant-GFP11 
and pETGFP1–10 were grown, and SteTmutant-GFP11 expression 
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a stream of nitrogen to obtain a thin layer. The dried lipids were 
resuspended in dialysis buffer (120 mM KPi, pH 7.4, 0.5 mM 
EDTA, 1 mM MgSO4, 5 mM TrisSO4, and 1% [wt/vol] glycerol) 
and 4 mM l-Ser to yield a final lipid concentration of 40 mg/ml. 
After four cycles of sonication and vortexing, the liposomes were 
extruded in a LiposoFast-Pneumatic Actuator (Avestin) through a 
400-nm polycarbonate filter to obtain unilamellar vesicles of 
homogeneous size. These vesicles were destabilized after adding 
1.25% (wt/vol) OG, mixed with the purified SteT version at a 
1:100 protein/lipid ratio (wt/wt), and incubated on ice with oc-
casional agitation for 5 min. Detergents were removed by dialysis 
(40 h and 4°C) using 100 sample volumes of dialysis buffer. 
Finally, the dialyzed proteoliposomes were pelleted by ultracen-
trifugation (100,000 g, 1 h, and 4°C) and resuspended in one 
third of the initial volume of dialysis buffer.
Transport measurements in proteoliposomes
Transport measurements were performed after a previously de-
scribed protocol (Reig et al., 2007) with minor changes. 10 µl of 
proteoliposomes containing no amino acids or 4 mM l-Ser were 
quickly mixed with 180 µl of transport buffer (150 mM choline 
chloride, 10 mM Tris-HEPES, pH 7.4, 1 mM MgCl2, 1 mM CaCl2, 
0.5 µCi l-[3H]Ser, and 10 µM l-Ser) and incubated at room tem-
perature for different periods of time. Reactions were stopped by 
the addition of 850 µl of ice-cold stop buffer (10 mM Tris-HEPES, 
pH 7.4, 150 mM choline chloride, and 5 mM l-Ser) and quickly fil-
trated through nitrocellulose membrane filters (Sartorius; 0.45-µm 
pore size). Filters were then washed three times with 2 ml of stop 
buffer and dried, and finally, the trapped radioactivity was quanti-
fied by scintillation counting. All experimental values were cor-
rected by subtracting the zero time values obtained by adding the 
stop solution in the transport buffer. Protein concentration in the 
proteoliposomes was determined using the amide black protein 
assay (Schaffner and Weissmann, 1973), and transport yield was ex-
pressed as pmol l-Ser/µg of protein and reported as the mean ± SE.
R E S U LT S
Construction and assessment of expression and folding  
of the SteT mutant library
A library of SteT random mutants was built using an 
error-prone PCR protocol previously optimized to pro-
duce a maximum of two amino acid substitutions per 
mutant. The low mutagenesis rate was intended to min-
imize any possible effect into the functional and struc-
tural integrity of SteT. Single or double mutants of SteT 
that expressed and folded properly in the host cytoplasmic 
membrane were selected using an assay based on the 
molecular complementation of the GFP (Rodríguez- 
Banqueri et al., 2012). In this method, a 15–amino acid 
fragment of an engineered superfolder GFP (GFP11; 
Pédelacq et al., 2006) is fused in the C-terminal end of 
SteT (Cabantous et al., 2005). GFP fluorescence is de-
tected if the GFP11 fragment complements with the 
remaining nonfluorescent 215–amino acid fragment 
of the GFP (GFP1–10), sequentially coexpressed in the 
same cell (Rodríguez-Banqueri et al., 2012). Importantly, 
GFP complementation will only take place if the mu-
tant is properly folded in the membrane (Rodríguez- 
Banqueri et al., 2012) because misfolded proteins are 
removed from the membrane and accumulated into 
Cloning SteT in pTTQ18-GFP-His(x10) for large-scale 
expression and protein purification
The cDNAs encoding SteT WT, L210Q/M229V, and I134V/
A377T were cloned between the EcoRI and PstI sites of the 
pTTQ18-GFP-His(x10) vector to generate the corresponding 
SteT variant containing the whole GFP at the C-terminal end fol-
lowed by a tail of 10 His. A HRV 3C protease recognition site 
(Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro) was also introduced between 
each SteT variant and the GFP. All constructs were verified by 
DNA sequencing. For protein expression, 4.8 liters of E. coli 
BL21(DE3) harboring the pTTQ18-SteTmutant-GFP-His(x10) 
plasmid were grown at a cell density of OD600 = 0.5; at this point, 
protein expression was induced after adding 0.5 mM IPTG and 
incubating overnight at 37°C. After protein induction, bacterial 
pellets were resuspended in 20 mM Tris-Base, pH 8.0, and 350 mM 
NaCl supplemented with cOmplete EDTA-free protease inhibitor 
cocktail and Pefabloc (Roche) at 0.2 g cell pellet/ml buffer. Cells 
were disrupted by passage through a cell disruptor (UK Constant 
Systems), three times at 20,000 psi. Cell debris and unbroken cells 
were removed by centrifugation (1 h, 15,000 g, and 4°C). The su-
pernatant was then ultracentrifuged (2 h, 200,000 g, and 4°C), 
and the membrane pellet was resuspended and homogenized 
in resuspension buffer (20 mM Tris-Base, pH 8.0, 150 mM NaCl, 
and 10% [wt/vol] glycerol). Membrane suspensions were ali-
quoted, frozen in liquid nitrogen, and stored at 80°C until use. 
Expression of the different SteT variants was tested by Western 
blot analysis using the HisProbe-HRP (Thermo Fisher Scientific) 
against the His-tag epitope.
Membrane suspension containing 3 mg/ml of total protein 
concentration was solubilized in 1% (wt/vol) DDM under agita-
tion for 1 h at 4°C. Insolubilized material was removed after 
ultracentrifugation at 120,000 g, 1 h, and 4°C. The resulting su-
pernatant was then incubated for 2 h and 4°C with Ni-NTA beads 
(QIAGEN) previously equilibrated with resuspension buffer con-
taining 0.01% (wt/vol) DDM and 10 mM imidazole. After incuba-
tion, resin was washed sequentially with 10 bead volumes of 
washing buffer (20 mM Tris-Base, pH 8.0, 150 mM NaCl, 0.01% 
[wt/vol] DDM, 10 mM imidazole, and 10% [wt/vol] glycerol), 10 
bead volumes of washing buffer plus 20 mM imidazole, and fi-
nally, 10 bead volumes of washing buffer with 40 mM imidazole. 
Protein was eluted after incubating the beads with elution buffer 
(20 mM Tris-Base, pH 8.0, 150 mM NaCl, 10% [wt/vol] glycerol, 
0.01% [wt/vol] DDM, and 350 mM imidazole) for 30 min. After 
elution, imidazole was removed using PD-10 desalting columns 
(GE Healthcare) and incubated with HVR 3C protease (1:20 
mol/mol protease/protein) with agitation in protease digestion 
buffer (20 mM Tris-Base, pH 8.0, 150 mM NaCl, 0.01% [wt/vol] 
DDM, 10% [wt/vol] glycerol, 0.5 mM EDTA, and 1 mM DTT) 
for 22 h at 4°C. After protease digestion, His(x10)-tagged GFP 
as well as His(x10)-tagged nondigested protein were removed by 
incubating the sample with Ni-NTA beads for 2 h at 4°C. Non-
bound purified digested protein was concentrated in Vivaspin 
100 MWCO concentrators (Sartorius) and after an ultracentrifu-
gation step (100,000 g, 30 min) to remove possible aggregates, 
injected in the SEC columns (Superdex 200 5/150 or Superdex 
200 10/300 GL; GE Healthcare). Columns were equilibrated with 
20 mM Tris-Base, pH 8.0, 150 mM NaCl, and 0.01% (wt/vol) 
DDM. Detergent exchange of purified proteins was performed 
during protein concentration by successive cycles of protein con-
centration and dilution in the new detergent and during SEC 
using a final concentration of 2× critical micelle concentration 
(CMC) of each detergent in the running buffer.
Reconstitution of SteT WT, L210Q/M299, and I134V/A377T 
into proteoliposomes
E. coli polar lipids (Avanti Polar Lipids, Inc.) solubilized in chloro-
form at 50 mg/ml concentration were dried in a glass tube under 
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inclusion bodies (Luirink et al., 2012). Consequently, if 
the random mutation drastically affects expression or 
membrane insertion and stability, no fluorescence will be 
detected. Sequential expression of SteT–random mu-
tant–GFP11 and GFP1–10 was performed directly in agar 
LB plates containing E. coli colonies transformed with the 
cDNA product resulting from the random mutagenesis 
and cloning reaction; therefore, each colony contained 
the cDNA that encoded an individual SteT random mu-
tant. This strategy quickly discards misfolded or non-
expressing mutants before DNA sequencing. In addition, 
attaching only a small portion of the GFP to SteT mini-
mizes any effect related with the presence of the whole 
GFP during protein translation and membrane inser-
tion. After colony selection and DNA sequencing, only 
mutants with substitutions localized in the TMDs of SteT 
were considered for the final library. The TMDs of SteT 
were defined using hydrophobicity plots and a 3-D struc-
tural model of SteT (Fig. 1; Bartoccioni et al., 2010). A 
final library of 70 random mutants of SteT (Table 1) with 
mutations distributed along the 12 TMDs of SteT was fur-
ther analyzed for membrane expression and homoge-
neity in detergent micelles. In this library, 41 mutants 
(59%) contained single amino acid substitutions and 29 
(41%) double amino acid substitutions.
Expression and detergent stability of SteT random mutants
The 70 SteT random mutants (Table 1) were solubilized 
in DDM from E. coli membranes and subjected to FSEC 
analysis (Kawate and Gouaux, 2006). FSEC permits an 
accurate evaluation of the degree of monodispersity in 
detergent of nonpurified GFP-tagged membrane pro-
teins by simply analyzing the shape and retention time 
of the chromatograms using the fluorescence of the 
TA B L E  1
SteT random mutants studied in this paper
Mutant TMD
L247M 7
L63R 2
L52Q 2
A305T/T410S 8–12
F49Y/L297V 2–8
I243P/A383S 7–11
P226Q 7
M392V 11
I235V 7
F89S/A105T 3–3
I235F 7
G61D/L78V 2–3
G62C/F304S 2–8
I285V 8
L199P 6
A197V/G232D 6–7
G152D/V370M 1-9
G69D 2
G87D 3
F49Y 2
F16L/I99V 1–3
R374C 10
T159I/S298T 5–8
P34Q 1
I132F 4
F371I/C415Y 10–12
V154E/G161S 5–5
L247V 7
G215D 6
G23R 1
A136E 4
G103S/L279P 3–8
A369G 9
G35R/G55D 1–2
L199M/L417M 6–12
A196T 6
C141W 4
E67K/E308K 2–8
F203S/R376P 6–10
F139L 4
G123D/I164T 3–5
I107F/H249Y 3–7
G54S 2
F49Y/N347Y 2–9
I336N/M413S 9–12
F402S 11
A60E/C168R 2–5
A267V 8
M32V/M342L 1–9
A424T 12
A109P 3
A398P 11
G283V 8
F31I 1
G27A/T156S 1–5
R374H 10
Mutant TMD
L53P 2
F391Y 11
W51R/L338Q 2–9
L14Q/T230A 1–7
F31L 1
A39F 1
A339D 11
L210Q/M229V 6–7
N193D 6
G161N 5
C291S 8
S303T 8
I134V/A377T 4–10
C168Y/L233M 5–7
Mutants were generated by error-prone PCR according the protocol 
described in Materials and methods. The TMD column indicates the 
number of TMDs where the substitutions are located. Mutants are 
ordered as in Fig. 3, on the basis of their relative expression yield with 
respect to WT.
Table 1 (Continued)
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WT in DDM, whereas mutants with IM <1 present less 
monodispersity in DDM than WT. In parallel, the ex-
pression yield of each mutant was quantified using the 
fluorescence of GFP after in vivo complementation. 
Measuring expression yields using the split GFP com-
plementation assay ensured that the protein fraction 
present in the membrane and later solubilized in DDM 
micelles is the only fraction quantified because poorly 
stable mutants are removed from the membrane and 
stored in inclusion bodies that do not emit fluorescence 
(Rodríguez-Banqueri et al., 2012). Normalized values 
of expression yield versus WT of each mutant are plot-
ted together with their respective IM in Fig. 3.
Overall effect of introducing random mutations in SteT TMDs
The results in Fig. 3 indicate that mutating residues lo-
cated in TMDs more frequently resulted in a decrease 
of protein expression yield, in an IM <1, or both (Fig. 3). 
In particular, 69% of mutants expressed less than WT 
GFP as readout. The aggregation state and therefore 
the stability of each SteT mutant in the conditions 
tested can be easily monitored from the chromato-
gram. DDM was the detergent of choice because it has 
shown before its ability to efficiently solubilize SteT 
in a functional state (Reig et al., 2007). As illustrated 
in Fig. 2, most of the SteT random mutants eluted as 
monomers with similar retention as WT; however, 
changes in the shape of the elution peak of the differ-
ent mutants revealed different degrees of aggregation 
as a consequence of instability (examples in Fig. 2). 
These changes were evaluated and compared with 
WT’s chromatogram after assigning a numeric value to 
each chromatogram named IM (Fig. 3). This index is 
calculated by dividing the area under the curve of the 
elution peak of each mutant by the corresponding area 
of WT’s elution peak (Eq. 1; see Materials and methods 
for full description). Thus, mutants with IM >1 are 
more monodisperse and therefore more stable than 
Figure 2. Examples of normalized FSEC profiles of SteT-GFP variants. To compare the monodispersity in DDM of each SteT mutant, 
FSEC chromatograms were normalized and overlapped. (A) A typical result of a double mutation (G35R/G55R) that causes a decrease 
of monodispersity in DDM. (B) The improving effect of the double mutation I134V/A377T on SteT monodispersity in DDM. RFU, 
relative fluorescent units.
Figure 3. Analysis of expression and monodispersity in DDM of SteT random mutants. The values of relative expression yield in E. coli 
of each mutant with respect to WT (left axis) are represented as shadow areas. These values were calculated using the split GFP assay and 
normalized with respect to the corresponding value of SteT WT. Mutants situated on the left of the dashed line show lower expression 
yield than WT, whereas mutants that show better expression yield are situated on the right side of this line. Vertical bars in the graph rep-
resent the values of the IM of a giving mutant (see Materials and methods for description). White bars correspond to mutants with worse 
monodispersity in DDM than WT (IM <1) and black bars correspond to mutants with better monodispersity in DDM than WT (IM >1).
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head groups (Sonoda et al., 2011). However, these de-
tergents can compromise protein stability in solution. 
Therefore, stability in these detergents is highly desir-
able when attempting to crystallize a membrane pro-
tein. In this line, we analyzed membrane solubilization 
and monodispersity in solution of SteT WT, L210Q/
M229V, and I134V/A377T in five different detergents 
(including DDM as control) with different hydrophobic 
tails and head groups: DM, OG, Cymal-6, and LDAO. 
The solubilization efficiency of all SteT variants after 
1 h of incubation in 1% (wt/vol) of a given detergent was 
fairly high (≥80%; not depicted), being slightly more ef-
ficient when solubilizing I134V/A377T (not depicted). 
Next, the monodispersity of nonpurified detergent-sol-
ubilized SteT WT, I134V/A377T, and L210Q/M229V in 
all detergents was monitored by FSEC. I134V/A377T 
and L210Q/M229V showed an improvement of SteT 
monodispersity in all detergents (Fig. 5) with the excep-
tion of LDAO, which induced a highly polydisperse be-
havior in all three SteT variants (not depicted).
L210Q/M229V and I134V/A377T catalyze l-Ser/l-Ser 
exchange in proteoliposomes
The residues replaced in L210Q/229V and I134V/
A377T are sitting away from the proposed substrate-bind-
ing site of SteT, situated near residue K295 who plays a 
key role in substrate recognition (Fig. 6; Bartoccioni 
et al., 2010). Indeed, the crystal structures of AdiC show 
that K295 homologous residue (Trp293) interacts with 
the substrate (Gao et al., 2010). Transport experiments 
were performed to investigate any possible alteration 
of the structural integrity of SteT as a consequence 
of these mutations, thus affecting substrate recogni-
tion and/or translocation. SteT WT, L210Q/229V, and 
and 60% had an IM <1. Among the mutants expressing 
more than WT, 27% (6 out of 22) presented an IM >1. 
These better performing mutants were the following: 
G283V, L14Q/T230A, G339D, L210Q/M229V, G161N, 
and I134V/A377T. Among them, the double mutants 
L210Q/M229V and I134V/A377T were the ones that 
presented the best-combined improvement of expres-
sion and monodispersity in DDM (Fig. 3). In contrast, 
only 4% of mutants expressing less than WT (2 out of 
48) presented an IM >1 (Fig. 3), suggesting that the sta-
bility in DDM micelles of a particular SteT mutant and 
its expression and stability in the host cytoplasmic mem-
brane could present some correlation. We used Pear-
son’s coefficients to analyze the correlation between 
expression and IM (Fig. 4). A slight linear relationship 
of both variables was confirmed by a Pearson’s coeffi-
cient of 0.41 (Fig. 4 A), where 1 is total positive correla-
tion and 0 is no correlation. We have analyzed separately 
the mutants regarding three subsets: expression levels 
higher than WT (Fig. 4 B), expression levels lower than 
WT (Fig. 4 C), and expression levels higher than WT 
and IM >1 (Fig. 4 D). The results showed a moderate 
(Pearson’s coefficient of 0.68; Fig. 4 B) and strong di-
rect relationship (Pearson’s coefficient of 0.83; Fig. 4 D) 
between both variables for mutants expressing higher 
than WT and mutants with higher expression than WT 
and IM >1, respectively.
L210Q/M229V and I134V/A377T retain monodispersity  
in detergents used for membrane protein crystallization
Protein–protein crystal contacts in membrane proteins 
are more likely to occur after reducing the size of pro-
tein–detergent micelles, normally achieved by using de-
tergents with shorter hydrophobic tails and/or smaller 
Figure 4. Correlation between expres-
sion and stability in detergent of the SteT 
random mutants. (A) Values of expression 
and IM from Fig. 3 were plotted and an-
alyzed using Pearson’s coefficients. (B–D) 
Mutants were also analyzed separately ac-
cording the following criteria: expression 
levels higher than WT (B), expression levels 
lower than WT (C), and expression levels 
higher than WT and IM >1 (D). The nu-
merical values of Pearson’s coefficients of 
each dataset are indicated in each panel.
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also displayed exchange activity as WT (Fig. 7), indicat-
ing that both sets of mutations do not substantially alter 
the overall fold of SteT, at least with regard to substrate 
binding. The transport activity of L210Q/M229V was 
somehow slower than that observed in WT and I134V/
A377T (Fig. 7). These experiments were repeated three 
times with similar results.
Stability of purified I134V/A377T and L210Q/M229V
We next performed stability tests of purified SteT WT, 
L210Q/M229V, and I134V/A377T at protein concentra-
tions and purity standards commonly used for structural 
studies. After DDM solubilization, affinity purification, 
and GFP-His tag removal by enzymatic digestion, SteT 
variants were concentrated up to 2 mg/ml (close to the 
limit of solubility of SteT WT [Reig et al., 2007]) and 
subjected to gel filtration chromatography (SEC) to 
evaluate their aggregation state. SEC profiles of L210Q/
M229V and I134V/A377T showed a clear monodisperse 
I134V/A377T with the GFP fused at the C-terminal end 
were purified by affinity chromatography, and their 
functional activity was tested after reconstitution into 
liposomes composed by E. coli lipids. The efficiency 
of reconstitution was similar in all three SteT variants, 
as judged by the GFP fluorescence in SDS-PAGE gels 
of reconstituted proteins (Fig. 7). Because SteT is an 
obligatory amino acid exchanger (as mammalian LATs), 
transport activity was measured monitoring the uptake 
of radioactive l-Ser into proteoliposomes previously 
loaded with a saturated concentration of cold l-Ser 
(Fig. 7). The net l-Ser uptake by SteT at different time 
intervals was calculated after subtracting counts ob-
tained in the l-Ser–loaded proteoliposomes from the 
ones obtained in empty proteoliposomes. l-Ser/l-Ser 
exchange activity of SteT WT fused to the GFP was sim-
ilar to that previously reported in the absence of the 
GFP (Fig. 7; Reig et al., 2007; Bartoccioni et al., 2010). 
The double mutants L210Q/M229V and I134V/A377T 
Figure 5. Normalized FSEC profiles of 
SteT WT, I134V/A377T, and L210Q/
M229V solubilized in DDM, DM, 
Cymal-6, and OG. (A–H) Normalized 
FSECs of SteT-I134V/A377T (A–D) and 
SteT-L210Q/M229V (E–H) were over-
lapped with the corresponding normal-
ized FSEC of SteT WT (dashed lines). 
SteT variants containing the GFP in the 
C-terminal end were solubilized from 
the membrane with DDM (A and E), 
DM (B and F), Cymal-6 (C and G), or 
OG (D and H) and injected into the 
gel filtration column equilibrated with 
a buffer containing 2× CMC of DDM. 
RFU, relative fluorescent units.
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ultracentrifuged to remove protein aggregates, and the 
remaining protein in the supernatant was quantified. 
Fig. 10 shows that after this treatment, only 50% of SteT 
WT remained in solution, whereas 80% of the two SteT 
mutants did not precipitate after this treatment.
I134V/A377T is stabilized with E. coli lipids
The 3-D model of SteT situates residues I134 and A377 
in the periplasmic and cytoplasmic sides of the mem-
brane, respectively, and likely oriented to the lipid 
phase (Fig. 6). We reasoned that changes in lipid–pro-
tein interactions caused by these mutations could ex-
plain (at least in part) the increase of expression and 
stability observed in I134V/A377T. To test this, we pro-
ceeded to analyze I134V/A377T monodispersity after 
sequential delipidation achieved by purifying I134V/
A377T at different concentrations of DDM. Although 
DDM is considered as a mild detergent, increasing the 
behavior, as judged by their single and symmetric SEC 
elution peak consistent with monomeric SteT (Fig. 8). 
In contrast, SteT WT presented polydispersity in the 
same conditions displaying a broader elution peak as 
well as high–molecular weight peaks (Fig. 8). Differ-
ences between WT and mutants are better appreciated 
in the overlapped chromatograms (Fig. 8). As with the 
experiments with nonpurified GFP-tagged proteins, we 
also analyzed the stability of L210Q/M229V and I134V/
A377T at 4 mg/ml in other detergents such as DM, 
NG, OG, and Cymal-6 (Fig. 9). As in the FSEC exper-
iments, the SEC profiles of the two purified SteT mu-
tants showed a monodisperse elution profile in all four 
detergents studied.
Stability in solution was also challenged after heating 
purified SteT WT, L210Q/M229V, and I134V/A377T 
in DDM. After incubating at 50°C for 30 min the puri-
fied proteins concentrated at 2 mg/ml, samples were 
Figure 6. Position of the amino acid 
replaced in SteT mutants L210Q/
M229V and I134V/A377T. Amino acid 
substitutions were modeled in a SteT 
3-D structural model (Bartoccioni et al., 
2010) and represented as spheres. Trans-
membrane segments are represented 
as cylinders, and only the TMDs con-
taining mutations are numbered. TMDs 
6 and 7 containing, respectively, the 
double substitution L210Q and M229V 
are colored in red, and TMDs 4 and 
10 containing, respectively, the substi-
tutions I134V and A377T are drawn in 
green. Residue K295 (TMD8), impli-
cated in substrate recognition in SteT 
(Bartoccioni et al., 2010), is also labeled 
and represented as blue spheres. (A) A 
lateral perspective of the molecule. 
(B) A periplasmic view after 60° rotation 
of A through the x axis. The gray shadow 
square in A represents the putative posi-
tion of the surrounding membrane.
Figure 7. Transport activity of SteT WT and the 
double mutants I134V/A377T and L210Q/M229V. 
Transport activity of each SteT version was analyzed 
from the time-dependent uptake curves of 10 µM ra-
diolabeled l-Ser into proteoliposomes formed after 
reconstituting each detergent-purified version of 
SteT, loaded with 4 mM l-Ser. The data points corre-
spond to the net transport activity of each SteT ver-
sion and were calculated after subtracting the data 
of nonloaded proteoliposomes from the data of pro-
teoliposomes loaded with l-Ser. Each data dataset 
is the mean of three independent experiments, and 
the SD is also represented. The figure also shows 
the GFP fluorescence in SDS-PAGE gels of the three 
proteins after reconstituting in proteoliposomes. 
SteT monomer fused to the GFP is the main band 
between 42 and 72 kD.
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became quickly incorporated into the mixed micelle, in-
creasing the apparent molecular mass of the micelle 
(Fig. 11, B–D). These experiments support the hypothe-
sis that the I134V/A377T replacements might favor the 
interaction between SteT and one of several polar lipid 
components of the E. coli membrane, and this could play 
some important role during protein expression and sta-
bilization after detergent solubilization.
D I S C U S S I O N
Finding general recipes to produce enough quantity 
of polytopic membrane proteins with enough purity 
and stability for structural studies is a remarkable chal-
lenge. This is probably more difficult for membrane 
transporters because in addition to their metastable 
nature, the large conformational heterogeneity inherent 
to their function prevents the formation of ordered 
crystals needed for structure determination using x-ray 
diffraction. Membrane transporters (either primary or 
secondary transporters) comprise 20% of the solved 
structures of membrane proteins, although in humans 
they represent 30% of membrane proteins (Hediger 
et al., 2013). Protein engineering and, in particular, 
individual side chain substitutions in suitable positions 
of the protein have overcome some of these limitations 
(Abramson et al., 2003; Gao et al., 2010; Kowalczyk et al., 
2011), being fundamental in the crystallization of sev-
eral transporters. Unfortunately, the molecular mecha-
nism behind the stabilization effect of a point mutation 
is often difficult to interpret (Vaidehi et al., 2016; even 
after solving the 3-D structure), hampering the formu-
lation of general rules for future predictions. One of 
the most efficient approaches to optimize selected tar-
gets for structural studies consists of generating large 
libraries of mutants, very often by random amino acid 
replacements, with the goal of finding an evolved ver-
sion of the target using optimal screening methods. 
Indeed, the GPCR field has been largely benefited using 
number of detergent micelles in the washing buffer 
that passes through the protein bound to the Ni-NTA 
beads results in a progressive elimination of lipids from 
the mixed protein–detergent–lipid micelle (Harvey 
and Wysocki, 2015). Therefore, SEC chromatograms 
of I134V/A377T purified at 0.02, 0.03, 0.04, or 0.05% 
(wt/vol) DDM, respectively, were analyzed (Fig. 11 A). 
The results clearly revealed a progressive displace-
ment from monodisperse to polydisperse behavior 
upon increasing the concentration of DDM (Fig. 11 A), 
indicating the appearance of high–molecular weight 
aggregates resulting from delipidation. Indeed, the 
elution profile of I134V/A377T in 0.05% (wt/vol) 
DDM resembled the SteT WT SEC chromatogram in 
nondelipidating conditions (0.02% [wt/vol] DDM). 
Moreover, SEC profiles of purified I134V/A377T in 
0.05% (wt/vol) DDM but in the presence of 0.05, 0.1, 
or 0.2 mg/ml of E. coli lipids in both the purification 
and SEC buffers showed a progressive reversion of the 
polydisperse behavior, shifting from two to one pro-
tein elution peak upon increasing the concentration 
of E. coli lipids (Fig. 11 B). In contrast, when the same 
experiment was performed in SteT WT, we did not 
observe a complete shift from polydisperse to mono-
disperse elution profile upon adding the same amount 
of E. coli lipids in the buffers (Fig. 11 C). Similarly, re-
lipidation of L210Q/M229V, a stabilized SteT version 
whose mutated residues are hidden from the lipid 
phase (Fig. 6) gave a similar result as WT, where a 
monodisperse elution profile could not be achieved 
after E. coli lipid addition (Fig. 11 D). The displace-
ment of the retention time of the eluted protein toward 
higher apparent molecular mass in these experiments 
(Fig. 11, A–D) obeyed an increase of the apparent mo-
lecular mass of the mixed protein–detergent–lipid mi-
celle caused by the incorporation of either detergent or 
lipid molecules. Although increasing DDM concentra-
tions did not significantly change the apparent size of the 
micelle (Fig. 11 A), the E. coli lipids added in the buffer 
Figure 8. SEC profiles of DDM-purified SteT WT, I134V/A377T, and L210Q/M229V. Purified proteins from His-tag affinity chro-
matography were concentrated up to 2 mg/ml and injected in a Superdex 200 50/1 50G column. (A and B) Monodispersity in 
these experimental conditions was analyzed by overlapping the normalized chromatograms of SteT WT with I134V/A377T (A) and 
L210Q/M229V (B).
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side chain substitutions within these domains are ex-
pected to produce a bigger impact on protein stability 
(Thévenin and Lazarova, 2008; Dalbey et al., 2011).
As described previously for soluble proteins (Cabantous 
and Waldo, 2006), using the split GFP assay to measure 
protein expression and solubility allows discarding 
nonexpressing or poorly stable membrane proteins 
(or mutants) confined in inclusion bodies by the host 
(Rodríguez-Banqueri et al., 2012). The GFP can be 
fluorescent in inclusion bodies (García-Fruitós et al., 
2005); however, GFP11 and GFP1–10 do not complement 
inside them (Cabantous et al., 2005). Therefore, green 
colonies obtained after sequential coexpression of SteT-
mutants-GFP11 and GFP1–10 contained SteT versions 
with the ability to express and fold in the host cyto-
plasmic membrane.
this approach (Tate and Schertler, 2009; Schlinkmann 
and Plückthun, 2013).
In this work, we took the challenge of engineering SteT, 
the best-known prokaryotic paradigm of human LATs (Reig 
et al., 2007), to provide optimal expression and stability 
for crystallogenesis. SteT shares 30% of amino acid iden-
tity and transport mechanism with many LATs, particularly 
with LAT-1, LAT-2, or b0,+AT (Fig. 1; Reig et al., 2007). 
In addition, residues predicted to interact with the sub-
strate are highly conserved between SteT and LAT-1 
(Fig. 1; Geier et al., 2013). To find an optimized and 
stable version of SteT, we introduced random replace-
ments within the TMDs, building a library composed 
of single and double mutants. Interactions between 
TMDs are the major determinant in the assembly and 
stability of integral membrane proteins; consequently, 
Figure 9. SEC profiles of purified SteT 
I134V/A377T and L210Q/M229V in DM, 
NG, Cymal-6, and OG. Affinity purified 
proteins in DDM were concentrated up to 
4 mg/ml and injected into a Superdex 200 
50/1 50G column equilibrated with 2× 
CMC of the indicated detergent.
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This is consistent with our observations because muta-
tions that resulted in the introduction of bulkier side 
chains normally resulted in the decrease of SteT expres-
sion and monodispersity in DDM (IM <1). Indeed, 69% 
of mutants expressing less than WT (31 out of 48) pre-
sent this type of substitutions in at least one of the two 
mutations. In addition, the majority of these mutants 
(including those expressing more than WT) also pre-
sented an IM <1 (Fig. 3). This negative effect was even 
more pronounced when charged side chains were 
introduced (e.g., L63R, G67D/L78V, A197V/G232D, 
G152D/V370M, G69D, G87D, G23R, or A60E/C168R; 
Fig. 3). SteT contains a few glycines highly conserved in 
LATs and located in the TMDs (Fig. 1). Replacing some 
of these glycines (e.g., G23R, G23D/A197V, G35R/
G55D, G61D/L78V, or G215D) normally resulted in an 
IM <1 (Fig. 3). In this regard, a notable decay of both 
expression and DDM monodispersity was found in the 
G87D mutant (Fig. 3). G87 is the homologous residue 
of G105 in b0,+AT. The congenital mutation G105R 
in b0,+AT induces protein misfolding and degradation 
during biogenesis, ultimately leading to a pathology 
called cystinuria (Bröer and Palacín, 2011). This posi-
tion (G87 in SteT and G105 in b0,+AT) is located in the 
C-terminal end of the predicted reentrant loop between 
TMDs 2 and 3 (Gasol et al., 2004), suggesting a role of 
this reentrant loop for the stabilization of the overall 
fold of LATs. Expression and monodispersity were also 
reduced after introducing or replacing prolines (e.g., 
L53P, A109P, G103S/L279P, L279P, P34Q, or P226Q; 
Fig. 3), arguing for folding instability derived from the 
critical role of this side chain in transmembrane pro-
teins (Perálvarez-Marín et al., 2008).
Interestingly, replacements of nonpolar by polar resi-
dues in a few positions resulted in an increase of pro-
tein expression yield and stability in DDM. This is the 
case of mutants G161N, A339D, and L210Q/M229V. 
The glycine in position 161 (TMD5) is fairly well con-
served in LATs (Fig. 1). Modeling the G161N mutation 
situates the amide group of the asparagine in an H-bond 
distance of S287 (TMD8; Fig. 12), a residue highly con-
served in LATs. We suggest that this potential hydrogen 
bond interaction might help stabilizing the protein, im-
proving expression yield and monodispersity in DDM. 
Likewise, the alanine in position 339 (TMD9) is also 
highly conserved in LATs (Fig. 1) facing TMDs 3 and 4. 
It is conceivable that after introducing a negative charge 
in the middle of TMD9 (A339D), a new polar inter-
action might take place probably between TMD9 and 
TMDs 3 or 4 (Fig. 12), helping the observed increase of 
protein expression and stability in detergent. Similarly, 
in the double mutant L210Q/M229V, the L→Q substi-
tution in position 210 (TMD6) might also favor the for-
mation of new polar interactions between TMD6 and 
TMDs 3 and/or 10, explaining the observed increase of 
expression and stability of this mutant with respect to 
Although resistance to thermal denaturation (or 
thermostability) is commonly used to analyze and com-
pare protein stability upon the introduction of point 
mutations (Serrano-Vega et al., 2008; Miller and Tate, 
2011), other methods to measure stability like the analy-
sis of the SEC chromatogram after detergent solubili-
zation are well accepted. A monodisperse elution profile 
of a membrane protein solubilized in a particular deter-
gent is a direct proof of its stability in this particular 
detergent (Sonoda et al., 2011). Proteins nonoptimally 
solubilized tend rapidly to aggregate, leading to the ap-
pearance of wider and/or multiple peaks (polydisper-
sity) in the gel filtration chromatogram. In fact, there is 
a direct relationship between degree of monodispersity 
and probability of protein crystallization (Sonoda et al., 
2011). DDM is a mild detergent able to solubilize in a 
functional state many membrane proteins, including 
SteT (Reig et al., 2007; Bartoccioni et al., 2010). There-
fore, this detergent was used to solubilize and compare 
stability of the SteT mutant library by FSEC.
The screening of a pool of 70 SteT mutants with sub-
stitutions exclusively localized in the TMDs (Table 1) 
revealed that most of these replacements lead to either 
an impairment of expression or an increase of polydis-
persity after DDM solubilization (IM <1; Fig. 3). This 
low tolerance of substituting residues situated in TMDs 
has been observed previously with other membrane 
proteins (Martinez Molina et al., 2008). The interactions 
between TMDs are the main determinants of protein 
folding and membrane insertion (Walters and DeGrado, 
2006); consequently, amino acid substitutions in these 
domains are likely to negatively perturb the expression 
yield and stability of the protein. In addition, TMD in-
terfaces tend to be highly packed as the result of the 
presence of small residues (Walters and DeGrado, 2006). 
Figure 10. Stability of purified SteT WT, I134V/A377T, and 
L210Q/M229V after thermal denaturation. 2 mg/ml of purified 
proteins in DDM were incubated at 50°C for 30 min. The bars indi-
cate the remaining percentage of each indicated SteT version pres-
ent in the supernatant and measured after ultracentrifugation.
 Rodríguez-Banqueri et al. 365
higher than WT and IM >1 (Fig. 4 D). Optimal miscibil-
ity between the nascent protein and the host’s mem-
brane lipids appears to be a prerequisite to gain stability 
in DDM micelles as well as in other less mild detergents 
commonly used in membrane protein crystallization as 
DM, NG, OG, or Cymal-6 (Figs. 5 and 9). In this regard, 
it is documented that well-folded membrane proteins 
are more efficiently solubilized using mild detergents 
like DDM (Thomas and Tate, 2014) than partially mis-
folded ones.
From our screening, the double mutant I134V/A377T 
is the most robust version of SteT, as judged by its pro-
duction yield in E. coli and monodispersity behavior in 
various detergents (Figs. 3, 5, 8, and 9) or even stability 
against thermal denaturation (Fig. 10). In the SteT 3-D 
model, residues I334 and A377 are situated in opposite 
leaflets of the membrane where the side chains are 
likely oriented toward the phospholipid phase rather 
than toward other TMDs of the protein as in the case 
of L210Q/M229V (Fig. 6). In addition, I134V/A377T 
WT (Fig. 3). The apparent slow rate of this mutant to 
exchange l-Ser compared with WT (Fig. 7) also sug-
gests that these mutations could stabilize the protein 
in a particular conformer, probably through new in-
tra-TMD interactions (Smirnova and Kaback, 2003), re-
sulting in a decrease of the translocation rate. In any 
case, more experimental evidence is needed to verify 
this hypothesis. As stated earlier (Gratkowski et al., 
2001; Walther and Ulrich, 2014), our results also sup-
port the idea that the energy cost of introducing polar 
residues in specific positions within TMDs is compen-
sated by the energy of stabilizing the overall fold or spe-
cific structural conformers of the protein through the 
formation of polar interactions between TMDs.
Pearson coefficients revealed a correlation between 
the yield of stably expressed protein in the membrane 
(measured using the split GFP complementation assay) 
and stability after detergent solubilization (measured 
using FSEC; Figs. 3 and 4). This correlation was partic-
ularly strong in those mutants with expression yield 
Figure 11. Effect of E. coli membrane 
lipids in the monodispersity of purified 
SteT I134V/A377T, L210Q/M229V, 
and WT. (A) SteT I134V/A377T was 
solubilized from the membrane with 
1% (wt/vol) DDM and immobilized in 
Ni-NTA beads for affinity purification. 
Beads were divided and poured into 
four columns and washed with 5 col-
umn volumes of 0.02, 0.03, 0.04, and 
0.05% (wt/vol) DDM, respectively, in 
each column. Each protein sample was 
eluted from the affinity column and 
subjected to gel filtration chromatogra-
phy in a Superdex 200 10/30 column 
equilibrated with the same concen-
tration of DDM used in the affinity 
purification. By gradually increasing 
the concentration of DDM during pu-
rification, SteT I134V/A377T became 
less monodisperse as a result of the de-
lipidation effect of DDM. (B) Solubi-
lized SteT I134V/A377T in 1% (wt/vol) 
DDM was immobilized in Ni-NTA beads 
for affinity purification. Beads were di-
vided into three columns and washed 
with buffer containing no lipid or 0.05 
and 0.2 mg/ml E. coli lipids, respec-
tively, in each column, always in the 
presence of 0.05% (wt/vol) DDM (de-
lipidating conditions). Each protein 
sample was eluted from the affinity column and subjected to gel filtration chromatography in a Superdex 200 10/30 column equili-
brated with 0.05% (wt/vol) DDM and the same amount of E. coli lipids used in the affinity purification. As seen in the figure, even in 
the presence of delipidating conditions (washing the Ni-NTA beads with 0.05% [wt/vol] DDM), the presence of E. coli lipids kept SteT 
I134V/A377T monodisperse in a concentration-dependent manner. (C and D) Solubilized SteT WT (C) and L210Q/M229V (D) in 1% 
(wt/vol) DDM were immobilized in Ni-NTA beads for affinity purification. As in B, beads were divided into three columns and washed 
with buffer containing no lipid or 0.05 and 0.2 mg/ml E. coli lipids, respectively, in the presence of 0.02% and 0.05% (wt/vol) DDM for 
WT and L210Q/M229V, respectively. Each protein sample was eluted from the affinity column and subjected to gel filtration chroma-
tography in a Superdex 200 10/30 column equilibrated with 0.05% (wt/vol) DDM (0.02% in the case of WT) and the same amount of 
E. coli lipids used in the affinity purification. Even in the presence of 0.2 mg/ml E. coli lipids (and lower concentration of DDM in the 
case of WT: 0.02% [wt/vol] instead of 0.05%), both SteT variants eluted in a polydisperse manner.
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